24,973 reports of this reaction
1.8% of all ETANERCEPT reports
#10 most reported adverse reaction
PSORIASIS is the #10 most commonly reported adverse reaction for ETANERCEPT, manufactured by Immunex Corporation. There are 24,973 FDA adverse event reports linking ETANERCEPT to PSORIASIS. This represents approximately 1.8% of all 1,356,881 adverse event reports for this drug.
Patients taking ETANERCEPT who experience psoriasis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PSORIASIS is a less commonly reported adverse event for ETANERCEPT, but still significant enough to appear in the safety profile.
In addition to psoriasis, the following adverse reactions have been reported for ETANERCEPT:
The following drugs have also been linked to psoriasis in FDA adverse event reports:
PSORIASIS has been reported as an adverse event in 24,973 FDA reports for ETANERCEPT. This does not prove causation, but indicates an association observed in post-market surveillance data.
PSORIASIS accounts for approximately 1.8% of all adverse event reports for ETANERCEPT, making it a notable side effect.
If you experience psoriasis while taking ETANERCEPT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.